Preclinical Modeling
Our research
Our "Preclinical Modelling" research group, also based at the KiTZ, focuses on exploring multimodal therapies against pediatric high-grade glioma using 3D tumor cultures and in vivo models.
We utilize in utero electroporation to induce targeted genetic alterations in the developing murine brain. The resulting autochthonous, immunocompetent models closely recapitulate the microenvironment of patient tumors and allow us to investigate the disease on a subtype-specific level and to evaluate new treatment concepts.
We focus on investigating the interplay of modern treatment modalities. These include upfront combinations of radiation and targeted inhibitors, analysis of the tumor microenvironment and immunotherapies including CAR-T cells, as well as experimental gene therapies using lipid nanoparticles. Our aim is to reveal synergistic interactions between these different treatment modalities that will inform novel treatment concepts against these yet incurable brain tumors.